Report Overview
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Human Injection Flu Vaccine market size was estimated at USD 7635 million in 2023 and is projected to reach USD 12152.47 million by 2032, exhibiting a CAGR of 5.30% during the forecast period.
North America Human Injection Flu Vaccine market size was estimated at USD 2174.33 million in 2023, at a CAGR of 4.54% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Human Injection Flu Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Injection Flu Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Injection Flu Vaccine market in any manner.
Global Human Injection Flu Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Injection Flu Vaccine Market
Overview of the regional outlook of the Human Injection Flu Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Injection Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Injection Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Injection Flu Vaccine
1.2 Key Market Segments
1.2.1 Human Injection Flu Vaccine Segment by Type
1.2.2 Human Injection Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Injection Flu Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Human Injection Flu Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Injection Flu Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Injection Flu Vaccine Market Competitive Landscape
3.1 Global Human Injection Flu Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Injection Flu Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Human Injection Flu Vaccine Sales Sites, Area Served, Product Type
3.6 Human Injection Flu Vaccine Market Competitive Situation and Trends
3.6.1 Human Injection Flu Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Injection Flu Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Injection Flu Vaccine Industry Chain Analysis
4.1 Human Injection Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Injection Flu Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Injection Flu Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Human Injection Flu Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Human Injection Flu Vaccine Price by Type (2019-2025)
7 Human Injection Flu Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Injection Flu Vaccine Market Sales by Application (2019-2025)
7.3 Global Human Injection Flu Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Human Injection Flu Vaccine Sales Growth Rate by Application (2019-2025)
8 Human Injection Flu Vaccine Market Consumption by Region
8.1 Global Human Injection Flu Vaccine Sales by Region
8.1.1 Global Human Injection Flu Vaccine Sales by Region
8.1.2 Global Human Injection Flu Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Injection Flu Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Injection Flu Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Injection Flu Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Injection Flu Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Injection Flu Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Injection Flu Vaccine Market Production by Region
9.1 Global Production of Human Injection Flu Vaccine by Region (2019-2025)
9.2 Global Human Injection Flu Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Human Injection Flu Vaccine Production
9.4.1 North America Human Injection Flu Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Human Injection Flu Vaccine Production
9.5.1 Europe Human Injection Flu Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Human Injection Flu Vaccine Production (2019-2025)
9.6.1 Japan Human Injection Flu Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Human Injection Flu Vaccine Production (2019-2025)
9.7.1 China Human Injection Flu Vaccine Production Growth Rate (2019-2025)
9.7.2 China Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sanofi
10.1.1 Sanofi Human Injection Flu Vaccine Basic Information
10.1.2 Sanofi Human Injection Flu Vaccine Product Overview
10.1.3 Sanofi Human Injection Flu Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi Human Injection Flu Vaccine SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Human Injection Flu Vaccine Basic Information
10.2.2 CSL Human Injection Flu Vaccine Product Overview
10.2.3 CSL Human Injection Flu Vaccine Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL Human Injection Flu Vaccine SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Human Injection Flu Vaccine Basic Information
10.3.2 GSK Human Injection Flu Vaccine Product Overview
10.3.3 GSK Human Injection Flu Vaccine Product Market Performance
10.3.4 GSK Human Injection Flu Vaccine SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Human Injection Flu Vaccine Basic Information
10.4.2 Viatris Human Injection Flu Vaccine Product Overview
10.4.3 Viatris Human Injection Flu Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Human Injection Flu Vaccine Basic Information
10.5.2 AstraZeneca Human Injection Flu Vaccine Product Overview
10.5.3 AstraZeneca Human Injection Flu Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Human Injection Flu Vaccine Basic Information
10.6.2 Hualan Bio Human Injection Flu Vaccine Product Overview
10.6.3 Hualan Bio Human Injection Flu Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Human Injection Flu Vaccine Basic Information
10.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
10.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Human Injection Flu Vaccine Basic Information
10.8.2 Sinovac Human Injection Flu Vaccine Product Overview
10.8.3 Sinovac Human Injection Flu Vaccine Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 Jiangsu GDK
10.9.1 Jiangsu GDK Human Injection Flu Vaccine Basic Information
10.9.2 Jiangsu GDK Human Injection Flu Vaccine Product Overview
10.9.3 Jiangsu GDK Human Injection Flu Vaccine Product Market Performance
10.9.4 Jiangsu GDK Business Overview
10.9.5 Jiangsu GDK Recent Developments
10.10 KM Biologics
10.10.1 KM Biologics Human Injection Flu Vaccine Basic Information
10.10.2 KM Biologics Human Injection Flu Vaccine Product Overview
10.10.3 KM Biologics Human Injection Flu Vaccine Product Market Performance
10.10.4 KM Biologics Business Overview
10.10.5 KM Biologics Recent Developments
11 Human Injection Flu Vaccine Market Forecast by Region
11.1 Global Human Injection Flu Vaccine Market Size Forecast
11.2 Global Human Injection Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Injection Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region
11.2.4 South America Human Injection Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Injection Flu Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Injection Flu Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Injection Flu Vaccine by Type (2025-2032)
12.1.2 Global Human Injection Flu Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Injection Flu Vaccine by Type (2025-2032)
12.2 Global Human Injection Flu Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Injection Flu Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Injection Flu Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Injection Flu Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Human Injection Flu Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2022)
Table 10. Global Market Human Injection Flu Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Human Injection Flu Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Injection Flu Vaccine Product Type
Table 13. Global Human Injection Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Injection Flu Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Injection Flu Vaccine Market Challenges
Table 22. Global Human Injection Flu Vaccine Sales by Type (K MT)
Table 23. Global Human Injection Flu Vaccine Market Size by Type (M USD)
Table 24. Global Human Injection Flu Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Human Injection Flu Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Human Injection Flu Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Human Injection Flu Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Human Injection Flu Vaccine Sales (K MT) by Application
Table 30. Global Human Injection Flu Vaccine Market Size by Application
Table 31. Global Human Injection Flu Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Human Injection Flu Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Human Injection Flu Vaccine Market Share by Application (2019-2025)
Table 35. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Human Injection Flu Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Human Injection Flu Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Human Injection Flu Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Human Injection Flu Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Human Injection Flu Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Human Injection Flu Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Human Injection Flu Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Human Injection Flu Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Human Injection Flu Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Human Injection Flu Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Sanofi Human Injection Flu Vaccine Basic Information
Table 52. Sanofi Human Injection Flu Vaccine Product Overview
Table 53. Sanofi Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Sanofi Business Overview
Table 55. Sanofi Human Injection Flu Vaccine SWOT Analysis
Table 56. Sanofi Recent Developments
Table 57. CSL Human Injection Flu Vaccine Basic Information
Table 58. CSL Human Injection Flu Vaccine Product Overview
Table 59. CSL Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. CSL Business Overview
Table 61. CSL Human Injection Flu Vaccine SWOT Analysis
Table 62. CSL Recent Developments
Table 63. GSK Human Injection Flu Vaccine Basic Information
Table 64. GSK Human Injection Flu Vaccine Product Overview
Table 65. GSK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. GSK Human Injection Flu Vaccine SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Viatris Human Injection Flu Vaccine Basic Information
Table 70. Viatris Human Injection Flu Vaccine Product Overview
Table 71. Viatris Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Viatris Business Overview
Table 73. Viatris Recent Developments
Table 74. AstraZeneca Human Injection Flu Vaccine Basic Information
Table 75. AstraZeneca Human Injection Flu Vaccine Product Overview
Table 76. AstraZeneca Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Hualan Bio Human Injection Flu Vaccine Basic Information
Table 80. Hualan Bio Human Injection Flu Vaccine Product Overview
Table 81. Hualan Bio Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Hualan Bio Business Overview
Table 83. Hualan Bio Recent Developments
Table 84. Changchun Institute of Biological Human Injection Flu Vaccine Basic Information
Table 85. Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
Table 86. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Changchun Institute of Biological Business Overview
Table 88. Changchun Institute of Biological Recent Developments
Table 89. Sinovac Human Injection Flu Vaccine Basic Information
Table 90. Sinovac Human Injection Flu Vaccine Product Overview
Table 91. Sinovac Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Sinovac Business Overview
Table 93. Sinovac Recent Developments
Table 94. Jiangsu GDK Human Injection Flu Vaccine Basic Information
Table 95. Jiangsu GDK Human Injection Flu Vaccine Product Overview
Table 96. Jiangsu GDK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Jiangsu GDK Business Overview
Table 98. Jiangsu GDK Recent Developments
Table 99. KM Biologics Human Injection Flu Vaccine Basic Information
Table 100. KM Biologics Human Injection Flu Vaccine Product Overview
Table 101. KM Biologics Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. KM Biologics Business Overview
Table 103. KM Biologics Recent Developments
Table 104. Global Human Injection Flu Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Human Injection Flu Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Human Injection Flu Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Human Injection Flu Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Human Injection Flu Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Human Injection Flu Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Human Injection Flu Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Human Injection Flu Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Human Injection Flu Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Human Injection Flu Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Human Injection Flu Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Human Injection Flu Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Human Injection Flu Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Human Injection Flu Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Human Injection Flu Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Human Injection Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Injection Flu Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Human Injection Flu Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Human Injection Flu Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Injection Flu Vaccine Market Size by Country (M USD)
Figure 11. Human Injection Flu Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Injection Flu Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Injection Flu Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Injection Flu Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Injection Flu Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Injection Flu Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Human Injection Flu Vaccine by Type in 2023
Figure 20. Market Size Share of Human Injection Flu Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Human Injection Flu Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Injection Flu Vaccine Market Share by Application
Figure 24. Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Human Injection Flu Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Injection Flu Vaccine Market Share by Application (2019-2025)
Figure 27. Global Human Injection Flu Vaccine Market Share by Application in 2023
Figure 28. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Human Injection Flu Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Human Injection Flu Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Human Injection Flu Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Human Injection Flu Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Human Injection Flu Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Human Injection Flu Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Human Injection Flu Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Human Injection Flu Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Human Injection Flu Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Human Injection Flu Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Injection Flu Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Injection Flu Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Injection Flu Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Human Injection Flu Vaccine Market Share Forecast by Application (2025-2032)
